653 related articles for article (PubMed ID: 32546134)
21. Antidepressants in epilepsy.
Górska N; Słupski J; Cubała WJ; Wiglusz MS; Gałuszko-Węgielnik M
Neurol Neurochir Pol; 2018; 52(6):657-661. PubMed ID: 30131174
[TBL] [Abstract][Full Text] [Related]
22. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial.
Kessing LV; Ziersen SC; Andersen FM; Gerds T; Budtz-Jørgensen E
Acta Psychiatr Scand; 2024 May; 149(5):378-388. PubMed ID: 38379028
[TBL] [Abstract][Full Text] [Related]
23. Association between haemorrhages and treatment with selective and non-selective serotonergic antidepressants: Possible implications of quantitative signal detection.
Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Muche R; Freudenmann RW; Schönfeldt-Lecuona C
Psychiatry Res; 2015 Sep; 229(1-2):257-63. PubMed ID: 26208982
[TBL] [Abstract][Full Text] [Related]
24. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA
J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132
[TBL] [Abstract][Full Text] [Related]
25. Association of antidepressants plus antithrombotics and bleeding risk: a pharmacovigilance study.
Montastruc JL; Bura-Rivière A
Eur J Clin Pharmacol; 2024 Feb; 80(2):283-285. PubMed ID: 38112734
[TBL] [Abstract][Full Text] [Related]
26. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
Schlienger RG; Fischer LM; Jick H; Meier CR
Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
[TBL] [Abstract][Full Text] [Related]
27. Risk of hair loss with different antidepressants: a comparative retrospective cohort study.
Etminan M; Sodhi M; Procyshyn RM; Guo M; Carleton BC
Int Clin Psychopharmacol; 2018 Jan; 33(1):44-48. PubMed ID: 28763345
[TBL] [Abstract][Full Text] [Related]
28. Antidepressant-induced tardive syndrome: a retrospective epidemiological study.
Lee Y; Lin PY; Chang YY; Chong MY; Cheng AT
Pharmacopsychiatry; 2013 Nov; 46(7):281-5. PubMed ID: 24057776
[TBL] [Abstract][Full Text] [Related]
29. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
[TBL] [Abstract][Full Text] [Related]
30. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Ishima T; Fujita Y; Hashimoto K
Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
[TBL] [Abstract][Full Text] [Related]
31. Drugs for depressionr.
Med Lett Drugs Ther; 2023 Dec; 65(1691):193-200. PubMed ID: 38133585
[No Abstract] [Full Text] [Related]
32. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database.
Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ;
J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889
[TBL] [Abstract][Full Text] [Related]
33. Other Antidepressants.
Schwasinger-Schmidt TE; Macaluso M
Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
[TBL] [Abstract][Full Text] [Related]
34. [Movement disorders due to modern antidepressants and mood stabilizers].
Vandewalle W; Boon E; Sienaert P
Tijdschr Psychiatr; 2015; 57(2):132-7. PubMed ID: 25669952
[TBL] [Abstract][Full Text] [Related]
35. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
[TBL] [Abstract][Full Text] [Related]
36. Serotonin syndrome: A pharmacovigilance comparative study of drugs affecting serotonin levels.
Elli C; Novella A; Pasina L
Eur J Clin Pharmacol; 2024 Feb; 80(2):231-237. PubMed ID: 38032391
[TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
38. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.
Nguyen TT; Pariente A; Montastruc JL; Lapeyre-Mestre M; Rousseau V; Rascol O; Bégaud B; Montastruc F
Br J Clin Pharmacol; 2017 Mar; 83(3):612-622. PubMed ID: 27687785
[TBL] [Abstract][Full Text] [Related]
39. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
[TBL] [Abstract][Full Text] [Related]
40. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Llorca PM; Lançon C; Brignone M; Rive B; Salah S; Ereshefsky L; Francois C
Curr Med Res Opin; 2014 Dec; 30(12):2589-606. PubMed ID: 25249164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
